Magazine Article | June 1, 2021

An All-Canada COVID-19 Vaccine Solution

Source: Life Science Leader

By Louis Garguilo, Chief Editor, Outsourced Pharma

Providence Therapeutics, a Calgary, Ontario-based, emerging mRNA biopharma, has become a focal point in a national “Canada First” initiative to develop a domestic COVID-19 vaccine.

The story of how it came to achieve such notoriety is an interesting one that includes a pivot from its core therapeutic focus, the hiring of an American as company president, and the creation of a CDMO.

VIEW THE MAGAZINE ARTICLE!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of Life Science Leader? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: